Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WARRANTS TO PURCHASE COMMON STOCK
Does anyone have the current outstanding warrant count, along with their respective purchase prices?
It looks like they have hired the PR company for WPWR. Patience is an officer of both companies.(same last name, but different first names) I think I will pick up some MEEX just in case............!!
MEEXF is the other side of this transaction. If it works, they should receive significant license fees from WPWR. Thoughts?
"Nonbinding expression of interest" letters are receuved by public companies on a recurring basis. These letters do not require public disclosure until a positive reply occurs. As such, the BOD of ARIA may have had one or more inquiries presented to them.
I wonder what the cost was to Richmont Holdings for their stock? I imagine some was promotional, some was optioned and some was bought by excerising warrants. I hope they are not planning to flip their stock, but 10 million shares will result in one great flipper profit.
Can this be a merger of equals? JCOF annual sales of 12M and YT annual sales of 40M equals 2011/12 sales of 52M, with no growth factored in.(other than JCOF forcasted sales) If you were YT, what percentage of the new company would you settle for? Then, how many new shares will be issued to give you that percentage? Now we can see the post merger capitlazition. GLTA
Does anyone know if Mike Nesson has left the Company?
Can anyone provide us with the filing number of IM3 510k filing? I have searched the FDA site for filing information under the various names, and nothing can be found. I need some help. TIA
MAYBE A PRESS RELEASE IN THE AM, PRECEEDING THE CONFERENCE CALL. COULD IT BE AN ANNOUCEMENT OF FDA APPROVAL?
The FDA response is due by July 21, 2010 if the FDA 90 day response period is calculated using calendar days, and August 17, 2010 if you use working days. We will see what happens!!
My office lunch room needed a fresh air boost. When staff would cook the wierd things they eat for lunch (cabbage, broccoli and the likes) you could smell it all over the office. I put 2 ionic bulbs in the lunch room, and now the air smells great! I might even like to work now. Well, maybe not!
The visibility that IMGG management has is good for their credibility. The starting of a new company while one is working as CEO of another company bothers me. Many companies would not tolerate that kind of activity. Any knowledge learned or gained while in the employ of a company belongs to that company. Conflicts of interest have caused many ships to sink. It would not happen if the BOD of IM3 were truly independent. They would at a minimum require a right of first refusal to any valuable deals that the CEO digs up. It really surprises me that Dean jumped into the other company prior to finishing his charge at IM3. The only reason must be an almost inked sell out with no carry over employment conditions. We will find out as time moves on!
This message from Mike Nesson on the investor forumn is enough to give this stock a $5.00 per share value:
This article is not referring to Imaging3. I’m not sure which CT system it was but I know it’s not the DViS. Conservatively we are about 1% the radiation of a “typical CT”. I use “typical” because it varies from machine to machine but to be conservative Dean feels that as a rule we are at least 1% of the radiation of a larger slice CT and in many cases even less. Our device is low dose, low cost, mobile and performs more than one function at a fraction of the cost
Why does the buying public not wake up and start buying this stock is beyond me!
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 25, 2010, Adam Engel resigned from his positions as President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and director of Zevotek, Inc. (the “Company”) and from his positions of Secretary and director of Ionicbulb.com, Inc., the Company’s subsidiary.
On February 25, 2010, the Company’s board of directors appointed Robert Babkie as Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and director. Prior to his appointment, Mr. Babkie, 52, had been retired since 2008. Mr. Babkie has over 27 years executive officer experience managing international importing, exporting and trading businesses. From 1995 to 2008, he was president and chief executive officer of Babkie Stainless Corp., an international trading firm specializing in the import and export of stainless steel. The U.S. based company had an international customer base, was closely engaged in doing business in China and had core competencies in selling stainless steel, warehousing and logistics and trade financing. From 1980 to 1985, Mr. Babkie was vice president and sales manager of Babkie International Corp., an international trading firm specializing in the import and export of non-ferrous metals.
Item 9.01 Financial Statements and Exhibits.
Exhibit
Number Description
99.1
Resignation of Adam Engel
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ZEVOTEK, INC.
(Registrant)
Date: February 26, 2010 By: /s/ Robert Babkie
Robert Babkie
President and Chief Executive Officer
.
How does this product differ from the Viatek ionic blub?
http://www.amazon.com/Ionic-Watt-Freshening-Light-Viatek/dp/B000ULXC6I/ref=sr_1_23?ie=UTF8&s=home-garden&qid=1261965800&sr=1-23
They need to buy the stock to cover their short. Don't sell it to them!!!
How much is enough? With over 100 million shares in the hands of key management people, and additional shares available to them from options, how much value are they looking for? Is personal wealth of 100 million a target? 200 million a target? What sounds reasonable. The buyers of the company will be concerned with the sellers wants, and that is what they will satisfy, anyway they can. The sellers are the people they deal with, not the shareholders as a group. We will get only what they want us to get. The good news is that we are attached to them with glue. Lets try to figure out what they really want to do after FDA approval. Sell out and float around on a boat, or operate a profitable and growing company?